Brainstorm Cell Therapeutics Inc.
Biotechnology company · New York, United States · OTC: BCLI
Brainstorm Cell Therapeutics Inc. is a biotechnology company headquartered in New York, United States. Its shares trade on OTC under the ticker BCLI. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2014.
Brainstorm Cell Therapeutics at a glance
What does Brainstorm Cell Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $10.5 million sold (2014).
Frequently asked questions about Brainstorm Cell Therapeutics
Where is Brainstorm Cell Therapeutics headquartered?
Brainstorm Cell Therapeutics Inc. is headquartered in New York, United States.
What does Brainstorm Cell Therapeutics do?
Brainstorm Cell Therapeutics Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Brainstorm Cell Therapeutics a public company?
Yes. Brainstorm Cell Therapeutics Inc. trades on OTC under the ticker BCLI.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.